Revance Therapeutics, Inc. (NASDAQ:RVNC) Q1 2024 Earnings Call Transcript May 9, 2024
Revance Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Welcome to the Revance Therapeutics First Quarter2024 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions]. As a reminder, this call is being recorded today, Thursday, May...
